We investigated this possibility by evaluating the expression of the CRC stem cell markers CD44 and LGR5, and found that metformin treatment reduced CD44 mRNA levels in all the cell lines (Fig. 7a, left). The gene discussed is LGR5; the disease is colorectal carcinoma.